Veru (VERU) to Release Quarterly Earnings on Thursday

Veru (NASDAQ:VERU) is anticipated to post its quarterly earnings results before the market opens on Thursday, February 6th. Analysts expect Veru to post earnings of ($0.08) per share and revenue of $3.02 million for the quarter.

Veru (NASDAQ:VERU) last announced its earnings results on Monday, December 16th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. Veru had a negative return on equity of 92.88% and a negative net margin of 223.85%. On average, analysts expect Veru to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Veru Price Performance

Veru stock opened at $0.61 on Thursday. The company has a market cap of $89.47 million, a PE ratio of -2.18 and a beta of -0.53. The company has a fifty day moving average price of $0.75 and a two-hundred day moving average price of $0.80. Veru has a 12 month low of $0.36 and a 12 month high of $1.92.

Wall Street Analysts Forecast Growth

VERU has been the subject of a number of research reports. HC Wainwright reiterated a “buy” rating and issued a $3.00 target price on shares of Veru in a report on Thursday, January 2nd. Oppenheimer reaffirmed an “outperform” rating and set a $5.00 price target on shares of Veru in a research note on Tuesday, November 5th.

About Veru

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.